Trials / Completed
CompletedNCT01295346
Biomarkers of Mild and Moderate Traumatic Brain Injury
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 290 (actual)
- Sponsor
- Banyan Biomarkers, Inc · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess if putative brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injury severity, occurrence of complications, and outcome, in subjects with mild or moderate TBI. The assay will be evaluated in a sample population of subjects over the age of 18 who have been referred to the health care provider for closed head injury evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Head CT scan and blood draw |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2011-02-14
- Last updated
- 2017-08-08
Locations
7 sites across 2 countries: United States, Hungary
Source: ClinicalTrials.gov record NCT01295346. Inclusion in this directory is not an endorsement.